Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study

Elly Lugtenburg, I Avivi, H Berenschot, O Ilhan, JP Marolleau, A Nagler, A Rueda, M Tani, M Turgut, S Osborne, R Smith, M Pfreundschuh

Research output: Contribution to journalArticleAcademicpeer-review

41 Citations (Scopus)
6 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)1913-1922
Number of pages10
Issue number11
Publication statusPublished - 2017

Cite this